BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 18266834)

  • 1. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
    Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
    Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
    Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
    Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H; Takahashi M; Nakamura K; Kaneko F
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
    Hon KL; Leung TF; Ma KC; Li AM; Wong Y; Fok TF
    Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
    Shimada Y; Takehara K; Sato S
    J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
    Kwon YS; Oh SH; Wu WH; Bae BG; Lee HJ; Lee MG; Lee KH
    Exp Dermatol; 2010 Mar; 19(3):246-51. PubMed ID: 19758316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
    Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
    Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.
    Hashimoto S; Nakamura K; Oyama N; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
    J Dermatol Sci; 2006 Nov; 44(2):93-9. PubMed ID: 17008059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
    Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
    Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
    Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
    J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
    Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
    Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
    Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
    Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
    Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
    Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
    Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
    Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
    Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Expression of Bacterial Pattern Recognition Receptor NOD2 of Basophils and Microbicidal Peptides in Atopic Dermatitis.
    Wong CK; Chu IM; Hon KL; Tsang MS; Lam CW
    Molecules; 2016 Apr; 21(4):471. PubMed ID: 27077833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
    Ezzat MH; Sallam MA; Shaheen KY
    Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine levels in serum of children with atopic dermatitis with regard to severity and sensitization status.
    Ahrens B; Schulz G; Bellach J; Niggemann B; Beyer K
    Pediatr Allergy Immunol; 2015 Nov; 26(7):634-40. PubMed ID: 26102348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
    Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.